nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0975	0.133	CbGbCtD
Ondansetron—CYP3A7—Irinotecan—colon cancer	0.0975	0.133	CbGbCtD
Ondansetron—CYP3A7—Vincristine—colon cancer	0.0852	0.116	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0852	0.116	CbGbCtD
Ondansetron—CYP2C9—Capecitabine—colon cancer	0.0794	0.108	CbGbCtD
Ondansetron—CYP3A5—Irinotecan—colon cancer	0.0731	0.0996	CbGbCtD
Ondansetron—CYP3A5—Vincristine—colon cancer	0.0639	0.087	CbGbCtD
Ondansetron—CYP1A2—Fluorouracil—colon cancer	0.0522	0.0711	CbGbCtD
Ondansetron—CYP2C9—Fluorouracil—colon cancer	0.0471	0.0641	CbGbCtD
Ondansetron—CYP3A4—Irinotecan—colon cancer	0.0285	0.0388	CbGbCtD
Ondansetron—CYP3A4—Vincristine—colon cancer	0.0249	0.0339	CbGbCtD
Ondansetron—HTR3A—myenteric nerve plexus—colon cancer	0.0243	0.309	CbGeAlD
Ondansetron—SLC47A2—renal system—colon cancer	0.00629	0.08	CbGeAlD
Ondansetron—SLC47A2—digestive system—colon cancer	0.00516	0.0656	CbGeAlD
Ondansetron—SLC47A2—vagina—colon cancer	0.00455	0.0579	CbGeAlD
Ondansetron—HTR1B—blood vessel—colon cancer	0.00416	0.0529	CbGeAlD
Ondansetron—Myocardial ischaemia—Irinotecan—colon cancer	0.00238	0.0127	CcSEcCtD
Ondansetron—Myocardial ischaemia—Fluorouracil—colon cancer	0.00228	0.0122	CcSEcCtD
Ondansetron—Neoplasm malignant—Irinotecan—colon cancer	0.00224	0.012	CcSEcCtD
Ondansetron—SLC47A1—renal system—colon cancer	0.0022	0.028	CbGeAlD
Ondansetron—Raised liver function tests—Methotrexate—colon cancer	0.00207	0.011	CcSEcCtD
Ondansetron—Musculoskeletal pain—Vincristine—colon cancer	0.00199	0.0106	CcSEcCtD
Ondansetron—Supraventricular tachycardia—Capecitabine—colon cancer	0.00195	0.0104	CcSEcCtD
Ondansetron—CYP3A7—liver—colon cancer	0.00194	0.0246	CbGeAlD
Ondansetron—Hiccups—Irinotecan—colon cancer	0.00191	0.0102	CcSEcCtD
Ondansetron—HTR3A—digestive system—colon cancer	0.00184	0.0234	CbGeAlD
Ondansetron—Torsade de pointes—Capecitabine—colon cancer	0.00183	0.00976	CcSEcCtD
Ondansetron—SLC47A1—digestive system—colon cancer	0.0018	0.023	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—liver—colon cancer	0.00165	0.0209	CbGeAlD
Ondansetron—SLC47A1—vagina—colon cancer	0.00159	0.0203	CbGeAlD
Ondansetron—Myocardial ischaemia—Capecitabine—colon cancer	0.00159	0.00852	CcSEcCtD
Ondansetron—Hepatic failure—Vincristine—colon cancer	0.00159	0.00848	CcSEcCtD
Ondansetron—Injection site pain—Capecitabine—colon cancer	0.00157	0.00839	CcSEcCtD
Ondansetron—HTR1A—renal system—colon cancer	0.00152	0.0193	CbGeAlD
Ondansetron—Swelling—Fluorouracil—colon cancer	0.00151	0.00806	CcSEcCtD
Ondansetron—Hypoxia—Methotrexate—colon cancer	0.0015	0.00802	CcSEcCtD
Ondansetron—Visual disturbance—Irinotecan—colon cancer	0.00147	0.00784	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Irinotecan—colon cancer	0.00144	0.00767	CcSEcCtD
Ondansetron—Ventricular extrasystoles—Capecitabine—colon cancer	0.00142	0.00758	CcSEcCtD
Ondansetron—Liver disorder—Methotrexate—colon cancer	0.0014	0.00748	CcSEcCtD
Ondansetron—Urinary retention—Vincristine—colon cancer	0.00136	0.00725	CcSEcCtD
Ondansetron—KCNH2—renal system—colon cancer	0.00135	0.0172	CbGeAlD
Ondansetron—SLC47A1—liver—colon cancer	0.00134	0.0171	CbGeAlD
Ondansetron—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00128	0.00687	CcSEcCtD
Ondansetron—Hiccups—Capecitabine—colon cancer	0.00128	0.00685	CcSEcCtD
Ondansetron—Injection site reaction—Capecitabine—colon cancer	0.00127	0.00681	CcSEcCtD
Ondansetron—Hypokalaemia—Irinotecan—colon cancer	0.00126	0.00676	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00125	0.00669	CcSEcCtD
Ondansetron—Angina pectoris—Irinotecan—colon cancer	0.00117	0.00625	CcSEcCtD
Ondansetron—CYP1A2—renal system—colon cancer	0.00116	0.0147	CbGeAlD
Ondansetron—Dysuria—Vincristine—colon cancer	0.00115	0.00616	CcSEcCtD
Ondansetron—Angina pectoris—Fluorouracil—colon cancer	0.00112	0.00599	CcSEcCtD
Ondansetron—CYP3A5—renal system—colon cancer	0.00111	0.0142	CbGeAlD
Ondansetron—Acute coronary syndrome—Vincristine—colon cancer	0.00108	0.00579	CcSEcCtD
Ondansetron—Myocardial infarction—Vincristine—colon cancer	0.00108	0.00576	CcSEcCtD
Ondansetron—Sleep disorder—Capecitabine—colon cancer	0.00107	0.00574	CcSEcCtD
Ondansetron—Acute coronary syndrome—Irinotecan—colon cancer	0.00106	0.00564	CcSEcCtD
Ondansetron—Swelling—Capecitabine—colon cancer	0.00105	0.00563	CcSEcCtD
Ondansetron—Myocardial infarction—Irinotecan—colon cancer	0.00105	0.00561	CcSEcCtD
Ondansetron—CYP2E1—renal system—colon cancer	0.00104	0.0132	CbGeAlD
Ondansetron—Hepatic failure—Capecitabine—colon cancer	0.00103	0.00553	CcSEcCtD
Ondansetron—SLC47A1—lymph node—colon cancer	0.00103	0.0131	CbGeAlD
Ondansetron—KCNH2—bone marrow—colon cancer	0.00102	0.013	CbGeAlD
Ondansetron—Acute coronary syndrome—Fluorouracil—colon cancer	0.00101	0.0054	CcSEcCtD
Ondansetron—Myocardial infarction—Fluorouracil—colon cancer	0.00101	0.00537	CcSEcCtD
Ondansetron—Urinary tract infection—Fluorouracil—colon cancer	0.000997	0.00533	CcSEcCtD
Ondansetron—Atrial fibrillation—Capecitabine—colon cancer	0.000981	0.00524	CcSEcCtD
Ondansetron—Bradycardia—Irinotecan—colon cancer	0.000978	0.00523	CcSEcCtD
Ondansetron—KCNH2—vagina—colon cancer	0.000978	0.0124	CbGeAlD
Ondansetron—Haemoglobin—Irinotecan—colon cancer	0.000966	0.00516	CcSEcCtD
Ondansetron—Haemorrhage—Irinotecan—colon cancer	0.000961	0.00514	CcSEcCtD
Ondansetron—CYP1A2—digestive system—colon cancer	0.000948	0.0121	CbGeAlD
Ondansetron—Visual impairment—Irinotecan—colon cancer	0.000926	0.00495	CcSEcCtD
Ondansetron—Haemoglobin—Fluorouracil—colon cancer	0.000925	0.00494	CcSEcCtD
Ondansetron—Haemorrhage—Fluorouracil—colon cancer	0.00092	0.00492	CcSEcCtD
Ondansetron—Cardiac disorder—Vincristine—colon cancer	0.000916	0.0049	CcSEcCtD
Ondansetron—CYP3A5—digestive system—colon cancer	0.000914	0.0116	CbGeAlD
Ondansetron—CYP2C9—digestive system—colon cancer	0.0009	0.0114	CbGeAlD
Ondansetron—Angiopathy—Vincristine—colon cancer	0.000895	0.00479	CcSEcCtD
Ondansetron—Cardiac disorder—Irinotecan—colon cancer	0.000892	0.00477	CcSEcCtD
Ondansetron—Flushing—Irinotecan—colon cancer	0.000892	0.00477	CcSEcCtD
Ondansetron—Mediastinal disorder—Vincristine—colon cancer	0.000889	0.00475	CcSEcCtD
Ondansetron—Urinary retention—Capecitabine—colon cancer	0.000884	0.00473	CcSEcCtD
Ondansetron—Angiopathy—Irinotecan—colon cancer	0.000872	0.00466	CcSEcCtD
Ondansetron—Immune system disorder—Irinotecan—colon cancer	0.000868	0.00464	CcSEcCtD
Ondansetron—Mediastinal disorder—Irinotecan—colon cancer	0.000866	0.00463	CcSEcCtD
Ondansetron—CYP2E1—lymphoid tissue—colon cancer	0.000863	0.011	CbGeAlD
Ondansetron—Chills—Irinotecan—colon cancer	0.000862	0.00461	CcSEcCtD
Ondansetron—Arrhythmia—Irinotecan—colon cancer	0.000859	0.00459	CcSEcCtD
Ondansetron—Liver function test abnormal—Capecitabine—colon cancer	0.000858	0.00459	CcSEcCtD
Ondansetron—CYP2E1—digestive system—colon cancer	0.000853	0.0108	CbGeAlD
Ondansetron—Hypokalaemia—Capecitabine—colon cancer	0.000846	0.00452	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000837	0.00447	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000837	0.00447	CcSEcCtD
Ondansetron—CYP3A4—renal system—colon cancer	0.000836	0.0106	CbGeAlD
Ondansetron—Flatulence—Irinotecan—colon cancer	0.000824	0.00441	CcSEcCtD
Ondansetron—CYP2D6—renal system—colon cancer	0.000823	0.0105	CbGeAlD
Ondansetron—Arrhythmia—Fluorouracil—colon cancer	0.000822	0.00439	CcSEcCtD
Ondansetron—CYP3A5—vagina—colon cancer	0.000807	0.0103	CbGeAlD
Ondansetron—Asthma—Capecitabine—colon cancer	0.000804	0.00429	CcSEcCtD
Ondansetron—Erythema—Fluorouracil—colon cancer	0.000801	0.00428	CcSEcCtD
Ondansetron—Bronchospasm—Capecitabine—colon cancer	0.00079	0.00422	CcSEcCtD
Ondansetron—Agitation—Vincristine—colon cancer	0.000789	0.00422	CcSEcCtD
Ondansetron—Angina pectoris—Capecitabine—colon cancer	0.000783	0.00418	CcSEcCtD
Ondansetron—Ill-defined disorder—Irinotecan—colon cancer	0.000776	0.00415	CcSEcCtD
Ondansetron—Hepatic failure—Methotrexate—colon cancer	0.00077	0.00412	CcSEcCtD
Ondansetron—Vision blurred—Fluorouracil—colon cancer	0.000755	0.00404	CcSEcCtD
Ondansetron—Malaise—Irinotecan—colon cancer	0.000754	0.00403	CcSEcCtD
Ondansetron—Dysuria—Capecitabine—colon cancer	0.000751	0.00402	CcSEcCtD
Ondansetron—Syncope—Irinotecan—colon cancer	0.00075	0.00401	CcSEcCtD
Ondansetron—Convulsion—Vincristine—colon cancer	0.000744	0.00398	CcSEcCtD
Ondansetron—Loss of consciousness—Irinotecan—colon cancer	0.000735	0.00393	CcSEcCtD
Ondansetron—Visual disturbance—Methotrexate—colon cancer	0.00073	0.0039	CcSEcCtD
Ondansetron—Cough—Irinotecan—colon cancer	0.00073	0.0039	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Methotrexate—colon cancer	0.000715	0.00382	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00071	0.0038	CcSEcCtD
Ondansetron—Acute coronary syndrome—Capecitabine—colon cancer	0.000706	0.00378	CcSEcCtD
Ondansetron—CYP1A2—liver—colon cancer	0.000706	0.00898	CbGeAlD
Ondansetron—Discomfort—Irinotecan—colon cancer	0.000704	0.00376	CcSEcCtD
Ondansetron—Myocardial infarction—Capecitabine—colon cancer	0.000702	0.00375	CcSEcCtD
Ondansetron—Anaphylactic shock—Vincristine—colon cancer	0.000701	0.00375	CcSEcCtD
Ondansetron—Urinary tract infection—Capecitabine—colon cancer	0.000696	0.00372	CcSEcCtD
Ondansetron—Convulsion—Fluorouracil—colon cancer	0.000694	0.00371	CcSEcCtD
Ondansetron—Nervous system disorder—Vincristine—colon cancer	0.000688	0.00367	CcSEcCtD
Ondansetron—CYP3A4—digestive system—colon cancer	0.000686	0.00873	CbGeAlD
Ondansetron—Anaphylactic shock—Irinotecan—colon cancer	0.000683	0.00365	CcSEcCtD
Ondansetron—Chest pain—Fluorouracil—colon cancer	0.000682	0.00365	CcSEcCtD
Ondansetron—CYP3A5—liver—colon cancer	0.000681	0.00866	CbGeAlD
Ondansetron—Hepatobiliary disease—Capecitabine—colon cancer	0.000678	0.00362	CcSEcCtD
Ondansetron—CYP2D6—digestive system—colon cancer	0.000675	0.00859	CbGeAlD
Ondansetron—Discomfort—Fluorouracil—colon cancer	0.000674	0.0036	CcSEcCtD
Ondansetron—Shock—Irinotecan—colon cancer	0.000672	0.00359	CcSEcCtD
Ondansetron—CYP2C9—liver—colon cancer	0.00067	0.00853	CbGeAlD
Ondansetron—Nervous system disorder—Irinotecan—colon cancer	0.00067	0.00358	CcSEcCtD
Ondansetron—Hypotension—Vincristine—colon cancer	0.000655	0.0035	CcSEcCtD
Ondansetron—Bradycardia—Capecitabine—colon cancer	0.000655	0.0035	CcSEcCtD
Ondansetron—Anaphylactic shock—Fluorouracil—colon cancer	0.000654	0.0035	CcSEcCtD
Ondansetron—Haemoglobin—Capecitabine—colon cancer	0.000646	0.00346	CcSEcCtD
Ondansetron—Haemorrhage—Capecitabine—colon cancer	0.000643	0.00344	CcSEcCtD
Ondansetron—Nervous system disorder—Fluorouracil—colon cancer	0.000641	0.00343	CcSEcCtD
Ondansetron—Liver function test abnormal—Methotrexate—colon cancer	0.000639	0.00342	CcSEcCtD
Ondansetron—Tachycardia—Fluorouracil—colon cancer	0.000638	0.00341	CcSEcCtD
Ondansetron—Hypotension—Irinotecan—colon cancer	0.000638	0.00341	CcSEcCtD
Ondansetron—CYP2E1—liver—colon cancer	0.000635	0.00808	CbGeAlD
Ondansetron—KCNH2—lymph node—colon cancer	0.000632	0.00804	CbGeAlD
Ondansetron—Paraesthesia—Vincristine—colon cancer	0.00063	0.00336	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000623	0.00333	CcSEcCtD
Ondansetron—Visual impairment—Capecitabine—colon cancer	0.00062	0.00331	CcSEcCtD
Ondansetron—Paraesthesia—Irinotecan—colon cancer	0.000613	0.00328	CcSEcCtD
Ondansetron—Hypotension—Fluorouracil—colon cancer	0.000611	0.00327	CcSEcCtD
Ondansetron—Dyspnoea—Irinotecan—colon cancer	0.000609	0.00325	CcSEcCtD
Ondansetron—Erythema multiforme—Capecitabine—colon cancer	0.000608	0.00325	CcSEcCtD
Ondansetron—Somnolence—Irinotecan—colon cancer	0.000607	0.00324	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Vincristine—colon cancer	0.000605	0.00324	CcSEcCtD
Ondansetron—Fatigue—Vincristine—colon cancer	0.000604	0.00323	CcSEcCtD
Ondansetron—Eye disorder—Capecitabine—colon cancer	0.000601	0.00321	CcSEcCtD
Ondansetron—Pain—Vincristine—colon cancer	0.0006	0.0032	CcSEcCtD
Ondansetron—Constipation—Vincristine—colon cancer	0.0006	0.0032	CcSEcCtD
Ondansetron—Asthma—Methotrexate—colon cancer	0.000598	0.0032	CcSEcCtD
Ondansetron—Cardiac disorder—Capecitabine—colon cancer	0.000597	0.00319	CcSEcCtD
Ondansetron—Flushing—Capecitabine—colon cancer	0.000597	0.00319	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Irinotecan—colon cancer	0.000589	0.00315	CcSEcCtD
Ondansetron—Fatigue—Irinotecan—colon cancer	0.000589	0.00315	CcSEcCtD
Ondansetron—Paraesthesia—Fluorouracil—colon cancer	0.000587	0.00314	CcSEcCtD
Ondansetron—Pain—Irinotecan—colon cancer	0.000584	0.00312	CcSEcCtD
Ondansetron—Constipation—Irinotecan—colon cancer	0.000584	0.00312	CcSEcCtD
Ondansetron—Angiopathy—Capecitabine—colon cancer	0.000584	0.00312	CcSEcCtD
Ondansetron—Dyspnoea—Fluorouracil—colon cancer	0.000583	0.00312	CcSEcCtD
Ondansetron—Somnolence—Fluorouracil—colon cancer	0.000581	0.00311	CcSEcCtD
Ondansetron—Immune system disorder—Capecitabine—colon cancer	0.000581	0.00311	CcSEcCtD
Ondansetron—Mediastinal disorder—Capecitabine—colon cancer	0.00058	0.0031	CcSEcCtD
Ondansetron—Chills—Capecitabine—colon cancer	0.000577	0.00308	CcSEcCtD
Ondansetron—Arrhythmia—Capecitabine—colon cancer	0.000575	0.00307	CcSEcCtD
Ondansetron—Gastrointestinal pain—Vincristine—colon cancer	0.000573	0.00306	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000565	0.00302	CcSEcCtD
Ondansetron—Feeling abnormal—Irinotecan—colon cancer	0.000563	0.00301	CcSEcCtD
Ondansetron—Erythema—Capecitabine—colon cancer	0.00056	0.00299	CcSEcCtD
Ondansetron—Dysuria—Methotrexate—colon cancer	0.000559	0.00299	CcSEcCtD
Ondansetron—Pain—Fluorouracil—colon cancer	0.000559	0.00299	CcSEcCtD
Ondansetron—Gastrointestinal pain—Irinotecan—colon cancer	0.000558	0.00298	CcSEcCtD
Ondansetron—Abdominal pain—Vincristine—colon cancer	0.000554	0.00296	CcSEcCtD
Ondansetron—Body temperature increased—Vincristine—colon cancer	0.000554	0.00296	CcSEcCtD
Ondansetron—Flatulence—Capecitabine—colon cancer	0.000552	0.00295	CcSEcCtD
Ondansetron—Abdominal pain—Irinotecan—colon cancer	0.00054	0.00288	CcSEcCtD
Ondansetron—Body temperature increased—Irinotecan—colon cancer	0.00054	0.00288	CcSEcCtD
Ondansetron—Feeling abnormal—Fluorouracil—colon cancer	0.000539	0.00288	CcSEcCtD
Ondansetron—Drowsiness—Methotrexate—colon cancer	0.000533	0.00285	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000529	0.00283	CcSEcCtD
Ondansetron—Vision blurred—Capecitabine—colon cancer	0.000528	0.00282	CcSEcCtD
Ondansetron—Tremor—Capecitabine—colon cancer	0.000525	0.0028	CcSEcCtD
Ondansetron—Ill-defined disorder—Capecitabine—colon cancer	0.00052	0.00278	CcSEcCtD
Ondansetron—Urticaria—Fluorouracil—colon cancer	0.000519	0.00278	CcSEcCtD
Ondansetron—Body temperature increased—Fluorouracil—colon cancer	0.000517	0.00276	CcSEcCtD
Ondansetron—Hypersensitivity—Vincristine—colon cancer	0.000517	0.00276	CcSEcCtD
Ondansetron—CYP3A4—liver—colon cancer	0.000511	0.0065	CbGeAlD
Ondansetron—Malaise—Capecitabine—colon cancer	0.000505	0.0027	CcSEcCtD
Ondansetron—Hepatobiliary disease—Methotrexate—colon cancer	0.000504	0.0027	CcSEcCtD
Ondansetron—Hypersensitivity—Irinotecan—colon cancer	0.000503	0.00269	CcSEcCtD
Ondansetron—Asthenia—Vincristine—colon cancer	0.000503	0.00269	CcSEcCtD
Ondansetron—CYP2D6—liver—colon cancer	0.000503	0.0064	CbGeAlD
Ondansetron—Syncope—Capecitabine—colon cancer	0.000502	0.00268	CcSEcCtD
Ondansetron—Palpitations—Capecitabine—colon cancer	0.000495	0.00264	CcSEcCtD
Ondansetron—Loss of consciousness—Capecitabine—colon cancer	0.000492	0.00263	CcSEcCtD
Ondansetron—Asthenia—Irinotecan—colon cancer	0.00049	0.00262	CcSEcCtD
Ondansetron—Cough—Capecitabine—colon cancer	0.000489	0.00261	CcSEcCtD
Ondansetron—Hypersensitivity—Fluorouracil—colon cancer	0.000482	0.00258	CcSEcCtD
Ondansetron—Haemoglobin—Methotrexate—colon cancer	0.000481	0.00257	CcSEcCtD
Ondansetron—Diarrhoea—Vincristine—colon cancer	0.00048	0.00256	CcSEcCtD
Ondansetron—Haemorrhage—Methotrexate—colon cancer	0.000479	0.00256	CcSEcCtD
Ondansetron—Chest pain—Capecitabine—colon cancer	0.000477	0.00255	CcSEcCtD
Ondansetron—Anxiety—Capecitabine—colon cancer	0.000475	0.00254	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000473	0.00253	CcSEcCtD
Ondansetron—Discomfort—Capecitabine—colon cancer	0.000471	0.00252	CcSEcCtD
Ondansetron—Diarrhoea—Irinotecan—colon cancer	0.000467	0.0025	CcSEcCtD
Ondansetron—Dry mouth—Capecitabine—colon cancer	0.000466	0.00249	CcSEcCtD
Ondansetron—Dizziness—Vincristine—colon cancer	0.000464	0.00248	CcSEcCtD
Ondansetron—Pruritus—Fluorouracil—colon cancer	0.000463	0.00247	CcSEcCtD
Ondansetron—Visual impairment—Methotrexate—colon cancer	0.000461	0.00247	CcSEcCtD
Ondansetron—Erythema multiforme—Methotrexate—colon cancer	0.000453	0.00242	CcSEcCtD
Ondansetron—Dizziness—Irinotecan—colon cancer	0.000451	0.00241	CcSEcCtD
Ondansetron—Shock—Capecitabine—colon cancer	0.00045	0.0024	CcSEcCtD
Ondansetron—Nervous system disorder—Capecitabine—colon cancer	0.000448	0.0024	CcSEcCtD
Ondansetron—Eye disorder—Methotrexate—colon cancer	0.000447	0.00239	CcSEcCtD
Ondansetron—Diarrhoea—Fluorouracil—colon cancer	0.000447	0.00239	CcSEcCtD
Ondansetron—Tachycardia—Capecitabine—colon cancer	0.000446	0.00238	CcSEcCtD
Ondansetron—Vomiting—Vincristine—colon cancer	0.000446	0.00238	CcSEcCtD
Ondansetron—Cardiac disorder—Methotrexate—colon cancer	0.000444	0.00238	CcSEcCtD
Ondansetron—Skin disorder—Capecitabine—colon cancer	0.000444	0.00237	CcSEcCtD
Ondansetron—Rash—Vincristine—colon cancer	0.000442	0.00236	CcSEcCtD
Ondansetron—Dermatitis—Vincristine—colon cancer	0.000442	0.00236	CcSEcCtD
Ondansetron—Headache—Vincristine—colon cancer	0.000439	0.00235	CcSEcCtD
Ondansetron—Angiopathy—Methotrexate—colon cancer	0.000434	0.00232	CcSEcCtD
Ondansetron—Vomiting—Irinotecan—colon cancer	0.000434	0.00232	CcSEcCtD
Ondansetron—Immune system disorder—Methotrexate—colon cancer	0.000432	0.00231	CcSEcCtD
Ondansetron—Dizziness—Fluorouracil—colon cancer	0.000432	0.00231	CcSEcCtD
Ondansetron—Mediastinal disorder—Methotrexate—colon cancer	0.000432	0.00231	CcSEcCtD
Ondansetron—Rash—Irinotecan—colon cancer	0.00043	0.0023	CcSEcCtD
Ondansetron—Dermatitis—Irinotecan—colon cancer	0.00043	0.0023	CcSEcCtD
Ondansetron—Chills—Methotrexate—colon cancer	0.00043	0.0023	CcSEcCtD
Ondansetron—Headache—Irinotecan—colon cancer	0.000428	0.00229	CcSEcCtD
Ondansetron—Hypotension—Capecitabine—colon cancer	0.000427	0.00228	CcSEcCtD
Ondansetron—Erythema—Methotrexate—colon cancer	0.000417	0.00223	CcSEcCtD
Ondansetron—Vomiting—Fluorouracil—colon cancer	0.000416	0.00222	CcSEcCtD
Ondansetron—Rash—Fluorouracil—colon cancer	0.000412	0.0022	CcSEcCtD
Ondansetron—Dermatitis—Fluorouracil—colon cancer	0.000412	0.0022	CcSEcCtD
Ondansetron—Paraesthesia—Capecitabine—colon cancer	0.00041	0.00219	CcSEcCtD
Ondansetron—Headache—Fluorouracil—colon cancer	0.00041	0.00219	CcSEcCtD
Ondansetron—Dyspnoea—Capecitabine—colon cancer	0.000407	0.00218	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Capecitabine—colon cancer	0.000395	0.00211	CcSEcCtD
Ondansetron—Fatigue—Capecitabine—colon cancer	0.000394	0.00211	CcSEcCtD
Ondansetron—Vision blurred—Methotrexate—colon cancer	0.000393	0.0021	CcSEcCtD
Ondansetron—Constipation—Capecitabine—colon cancer	0.000391	0.00209	CcSEcCtD
Ondansetron—Pain—Capecitabine—colon cancer	0.000391	0.00209	CcSEcCtD
Ondansetron—Ill-defined disorder—Methotrexate—colon cancer	0.000387	0.00207	CcSEcCtD
Ondansetron—Feeling abnormal—Capecitabine—colon cancer	0.000377	0.00201	CcSEcCtD
Ondansetron—Malaise—Methotrexate—colon cancer	0.000376	0.00201	CcSEcCtD
Ondansetron—Gastrointestinal pain—Capecitabine—colon cancer	0.000374	0.002	CcSEcCtD
Ondansetron—Cough—Methotrexate—colon cancer	0.000364	0.00194	CcSEcCtD
Ondansetron—Urticaria—Capecitabine—colon cancer	0.000363	0.00194	CcSEcCtD
Ondansetron—Abdominal pain—Capecitabine—colon cancer	0.000361	0.00193	CcSEcCtD
Ondansetron—Body temperature increased—Capecitabine—colon cancer	0.000361	0.00193	CcSEcCtD
Ondansetron—Convulsion—Methotrexate—colon cancer	0.000361	0.00193	CcSEcCtD
Ondansetron—Chest pain—Methotrexate—colon cancer	0.000355	0.0019	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000352	0.00188	CcSEcCtD
Ondansetron—Discomfort—Methotrexate—colon cancer	0.000351	0.00187	CcSEcCtD
Ondansetron—Anaphylactic shock—Methotrexate—colon cancer	0.00034	0.00182	CcSEcCtD
Ondansetron—Hypersensitivity—Capecitabine—colon cancer	0.000337	0.0018	CcSEcCtD
Ondansetron—Nervous system disorder—Methotrexate—colon cancer	0.000334	0.00178	CcSEcCtD
Ondansetron—Skin disorder—Methotrexate—colon cancer	0.00033	0.00177	CcSEcCtD
Ondansetron—Asthenia—Capecitabine—colon cancer	0.000328	0.00175	CcSEcCtD
Ondansetron—Pruritus—Capecitabine—colon cancer	0.000323	0.00173	CcSEcCtD
Ondansetron—Hypotension—Methotrexate—colon cancer	0.000318	0.0017	CcSEcCtD
Ondansetron—Diarrhoea—Capecitabine—colon cancer	0.000313	0.00167	CcSEcCtD
Ondansetron—Paraesthesia—Methotrexate—colon cancer	0.000305	0.00163	CcSEcCtD
Ondansetron—Dyspnoea—Methotrexate—colon cancer	0.000303	0.00162	CcSEcCtD
Ondansetron—Somnolence—Methotrexate—colon cancer	0.000302	0.00162	CcSEcCtD
Ondansetron—Dizziness—Capecitabine—colon cancer	0.000302	0.00162	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Methotrexate—colon cancer	0.000294	0.00157	CcSEcCtD
Ondansetron—Fatigue—Methotrexate—colon cancer	0.000293	0.00157	CcSEcCtD
Ondansetron—Pain—Methotrexate—colon cancer	0.000291	0.00155	CcSEcCtD
Ondansetron—Vomiting—Capecitabine—colon cancer	0.000291	0.00155	CcSEcCtD
Ondansetron—Rash—Capecitabine—colon cancer	0.000288	0.00154	CcSEcCtD
Ondansetron—Dermatitis—Capecitabine—colon cancer	0.000288	0.00154	CcSEcCtD
Ondansetron—Headache—Capecitabine—colon cancer	0.000286	0.00153	CcSEcCtD
Ondansetron—Feeling abnormal—Methotrexate—colon cancer	0.00028	0.0015	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methotrexate—colon cancer	0.000278	0.00149	CcSEcCtD
Ondansetron—Urticaria—Methotrexate—colon cancer	0.00027	0.00144	CcSEcCtD
Ondansetron—Abdominal pain—Methotrexate—colon cancer	0.000269	0.00144	CcSEcCtD
Ondansetron—Body temperature increased—Methotrexate—colon cancer	0.000269	0.00144	CcSEcCtD
Ondansetron—Hypersensitivity—Methotrexate—colon cancer	0.000251	0.00134	CcSEcCtD
Ondansetron—Asthenia—Methotrexate—colon cancer	0.000244	0.0013	CcSEcCtD
Ondansetron—Pruritus—Methotrexate—colon cancer	0.000241	0.00129	CcSEcCtD
Ondansetron—Diarrhoea—Methotrexate—colon cancer	0.000233	0.00124	CcSEcCtD
Ondansetron—Dizziness—Methotrexate—colon cancer	0.000225	0.0012	CcSEcCtD
Ondansetron—Vomiting—Methotrexate—colon cancer	0.000216	0.00116	CcSEcCtD
Ondansetron—Rash—Methotrexate—colon cancer	0.000214	0.00115	CcSEcCtD
Ondansetron—Dermatitis—Methotrexate—colon cancer	0.000214	0.00115	CcSEcCtD
Ondansetron—Headache—Methotrexate—colon cancer	0.000213	0.00114	CcSEcCtD
